Pilot of a Trial Enrollment Diversity Dashboard (TEDD)

Dana-Farber Cancer Institute

Status: Active, not recruiting

Conditions: Acute Leukemia; Leukemia

Treatments: Behavioral: Trial Enrollment Diversity Dashboard Behavioral

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06795139

24-544

K08CA273043-01 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The goal of this study is to test the feasibility of a data visualization tool called the Trial Enrollment Diversity Dashboard (TEDD) to ensure participant diversity in acute leukemia trial enrollment.

Full description

This study is about testing a tool called the Trial Enrollment Diversity Dashboard (TEDD) to see if it can help increase diversity in cancer clinical trials, specifically for leukemia. Clinical trials are important for developing new cancer treatments, but not all groups are equally represented in these trials. This can lead to treatments that may not work as well for everyone.

The TEDD tool is designed to give medical professionals feedback on how diverse their patient enrollments are clinical trials. By using this tool, medical professionals can see if they are enrolling a diverse group of patients and make changes if needed.

The study will involve a small group of medical professionals who treat leukemia patients. They will use the TEDD tool and provide feedback on its usability and effectiveness. Study procedures include completion of surveys and usage of the TEDD intervention dashboard.

It is expected that about 12 medical professionals will take part in this research study. Participation in this research study is expected to last about 14 months.

The National Cancer Institute is providing funding for this research study.

Enrollment: 12 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria Medical Professionals:

• Physician, nurse practitioner, or physician assistant

  -≥10% clinical effort (or one ½ day of clinic per week for those working <1 FTE)

• Treats adult patients with leukemia or related diseases at the study sites

• Ability to understand and willingness to provide informed consent

• Age 18 or older

Inclusion Criteria Participant Population:

• Age ≥18 years old
• Diagnosis of leukemia, lymphoma, myeloma, or related diseases
• Seen by a physician for this diagnosis at one of the study sites

Exclusion Criteria Medical Professionals:

-Listed member of the research team

Exclusion Criteria Participant Population:

-Participants without the diagnoses of interest listed above, participants not seen at the study sites.

Trial design

Primary purpose: Health Services Research

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

12 participants in 1 patient group

TEDD Intervention

Experimental group

Description:

12 medical professional participants will complete the following: * Baseline survey. * Usage and access of the TEDD intervention over a 12-month period. * Follow up surveys at the end of each quarter.

Treatment:

Behavioral: Trial Enrollment Diversity Dashboard Behavioral